Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Roxadustat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,078Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Evrenzo

    02 3Roxadustat

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Evrenzo

    Roxadustat

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Evrenzo

    Japan
    arrow
    PharmaVenue
    Not Confirmed

    Astellas

    Roxadustat

    Main Therapeutic Indication : Hematology

    Currency : USD

    2021 Revenue in Millions : 21

    2020 Revenue in Millions : 0

    Growth (%) : 100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Roxadustat

    Roxadustat

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Roxadustat

    United Kingdom
    arrow
    PharmaVenue
    Not Confirmed

    AstraZeneca

    Roxadustat

    Main Therapeutic Indication : Hematology

    Currency : USD

    2021 Revenue in Millions : 174

    2020 Revenue in Millions : 0

    Growth (%) : 100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Evrenzo

    Roxadustat

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Evrenzo

    Japan
    arrow
    PharmaVenue
    Not Confirmed

    Astellas

    Roxadustat

    Main Therapeutic Indication : Hematology

    Currency : USD

    2022 Revenue in Millions : 24

    2021 Revenue in Millions : 22

    Growth (%) : 11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Roxadustat

    Roxadustat

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Roxadustat

    United Kingdom
    arrow
    PharmaVenue
    Not Confirmed

    AstraZeneca

    Roxadustat

    Main Therapeutic Indication : Hematology

    Currency : USD

    2022 Revenue in Millions : 197

    2021 Revenue in Millions : 174

    Growth (%) : 13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Roxadustat

    Roxadustat

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Roxadustat

    United Kingdom
    arrow
    PharmaVenue
    Not Confirmed

    AstraZeneca

    Roxadustat

    Main Therapeutic Indication : Hematology

    Currency : USD

    2023 Revenue in Millions : 271

    2022 Revenue in Millions : 197

    Growth (%) : 38

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Evrenzo

    Roxadustat

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Evrenzo

    Japan
    arrow
    PharmaVenue
    Not Confirmed

    Astellas

    Roxadustat

    Main Therapeutic Indication : Hematology

    Currency : USD

    2023 Revenue in Millions : 5

    2022 Revenue in Millions : 24

    Growth (%) : -75

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF